跳至主要内容
临床试验/JPRN-UMIN000036672
JPRN-UMIN000036672已完成未知

Safety confirmation test by intake of plant extract - Safety confirmation test by intake of plant extract

Oneness support CO., LTD0 个研究点目标入组 0 人开始时间: 2021年5月16日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 64years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • (1) Liver disease, kidney disease, digestive system disease, heart disease, respiratory disorder, endocrine disorder, metabolic disorder, neurological disorder, consciousness disorder, diabetes, seizures, and other diseases that may affect the results of this test Person who has a medical history or who has a history of surgery (2) Patients who have been hospitalized for treatment due to stroke, subarachnoid hemorrhage, cerebral infarction, cerebral hemorrhage, brain contusion, head injury (3) Those who show abnormal liver function and renal function test values (4) Person who has disease under treatment now (5) Person with food and drug allergy (6) Person with anemia symptom (7) Those who have experienced ill mood or worsened physical condition by blood collection in the past (8) Those who donated more than 200 mL from the month before the start of the test to the start of the test, or those who have plans for it during the test period (9) Those who do intense sports and those who are on a diet (10) Person who has excessive smoking habit (11) Those who have an irregular diet (12) Those who can not quit the intake of health food (including food for specified health and functional indication food) and designated quasi-drugs during the test period (13) Those who are taking medication (including OTC and prescription drugs) continuously (14) Those who are taking alcohol excessively or who can not drink alcohol from the day before the test until the day (15) Persons who are pregnant or who are planning pregnancy or lactation during the study period (16) Those who are participating in or planning to participate in other clinical trials at the beginning of this trial, and within 4 weeks after the end of the trial (17) Others who are judged inappropriate by the investigator

研究者

发起方
Oneness support CO., LTD

相似试验